196 related articles for article (PubMed ID: 11846524)
61. [Amplification of portions of the genome in the somatic cells of mammals resistant to colchicine. IV. Genetic transformation using amplified genes from Djungarian hamster cells highly resistant to colchicine].
Kopnin BP; Gudkov AV
Genetika; 1983 Jun; 19(6):864-71. PubMed ID: 6684073
[TBL] [Abstract][Full Text] [Related]
62. Genetics. Leishmania exploit sex.
Miles MA; Yeo M; Mauricio IL
Science; 2009 Apr; 324(5924):187-9. PubMed ID: 19359570
[No Abstract] [Full Text] [Related]
63. Sterol 14α-demethylase mutation leads to amphotericin B resistance in Leishmania mexicana.
Mwenechanya R; Kovářová J; Dickens NJ; Mudaliar M; Herzyk P; Vincent IM; Weidt SK; Burgess KE; Burchmore RJS; Pountain AW; Smith TK; Creek DJ; Kim DH; Lepesheva GI; Barrett MP
PLoS Negl Trop Dis; 2017 Jun; 11(6):e0005649. PubMed ID: 28622334
[TBL] [Abstract][Full Text] [Related]
64. Amphotericin B-induced sensitivity to actinomycin D in drug-resistant Hela cells.
Medoff J; Medoff G; Goldstein MN; Schlessinger D; Kobayaski GS
Cancer Res; 1975 Sep; 35(9):2548-52. PubMed ID: 1149049
[TBL] [Abstract][Full Text] [Related]
65. In vitro susceptibility testing of Naegleria fowleri to ketoconazole, BAYn7133, and allopurinol riboside.
Smego RA; Durack DT
J Parasitol; 1984 Apr; 70(2):317-8. PubMed ID: 6088750
[No Abstract] [Full Text] [Related]
66. In vitro assays for evaluation of drug activity against Leishmania spp.
Fumarola L; Spinelli R; Brandonisio O
Res Microbiol; 2004 May; 155(4):224-30. PubMed ID: 15142618
[TBL] [Abstract][Full Text] [Related]
67. Roles for mitochondria in pentamidine susceptibility and resistance in Leishmania donovani.
Mukherjee A; Padmanabhan PK; Sahani MH; Barrett MP; Madhubala R
Mol Biochem Parasitol; 2006 Jan; 145(1):1-10. PubMed ID: 16219371
[TBL] [Abstract][Full Text] [Related]
68. Amplification of ABC transporter gene pgpA and of other heavy metal resistance genes in Leishmania tarentolae and their study by gene transfection and gene disruption.
Ouellette M; Haimeur A; Grondin K; Légaré D; Papadopoulou B
Methods Enzymol; 1998; 292():182-93. PubMed ID: 9711554
[No Abstract] [Full Text] [Related]
69. Antileishmanial activity of nano-amphotericin B deoxycholate.
Manandhar KD; Yadav TP; Prajapati VK; Kumar S; Rai M; Dube A; Srivastava ON; Sundar S
J Antimicrob Chemother; 2008 Aug; 62(2):376-80. PubMed ID: 18453526
[TBL] [Abstract][Full Text] [Related]
70. Preparation and antileishmanial activity of lipophilic N-alkyl diamines.
da Costa CF; Coimbra ES; Braga FG; dos Reis RC; da Silva AD; de Almeida MV
Biomed Pharmacother; 2009 Jan; 63(1):40-2. PubMed ID: 18262385
[TBL] [Abstract][Full Text] [Related]
71. High level arsenite resistance in Leishmania tarentolae is mediated by an active extrusion system.
Dey S; Papadopoulou B; Haimeur A; Roy G; Grondin K; Dou D; Rosen BP; Ouellette M
Mol Biochem Parasitol; 1994 Sep; 67(1):49-57. PubMed ID: 7838183
[TBL] [Abstract][Full Text] [Related]
72. Point mutations within the LdNT2 nucleoside transporter gene from Leishmania donovani confer drug resistance and transport deficiency.
Galazka J; Carter NS; Bekhouche S; Arastu-Kapur S; Ullman B
Int J Biochem Cell Biol; 2006; 38(7):1221-9. PubMed ID: 16464630
[TBL] [Abstract][Full Text] [Related]
73. Divergence of trypanothione-dependent tryparedoxin cascade into cytosolic and mitochondrial pathways in arsenite-resistant variants of Leishmania amazonensis.
Hsu JY; Lin YC; Chiang SC; Lee ST
Mol Biochem Parasitol; 2008 Feb; 157(2):193-204. PubMed ID: 18083246
[TBL] [Abstract][Full Text] [Related]
74. New terpenoids from Maytenus apurimacensis as MDR reversal agents in the parasite Leishmania.
Delgado-Méndez P; Herrera N; Chávez H; Estévez-Braun A; Ravelo AG; Cortes F; Castanys S; Gamarro F
Bioorg Med Chem; 2008 Feb; 16(3):1425-30. PubMed ID: 18035546
[TBL] [Abstract][Full Text] [Related]
75. Stable amplification of a linear extrachromosomal DNA in mycophenolic acid-resistant Leishmania donovani.
Wilson K; Beverley SM; Ullman B
Mol Biochem Parasitol; 1992 Oct; 55(1-2):197-206. PubMed ID: 1359409
[TBL] [Abstract][Full Text] [Related]
76. Naturally-occurring gene amplifications conferring drug resistance in Leishmania tarentolae.
Beverley SM; Petrillo-Peixoto M
Mem Inst Oswaldo Cruz; 1988 Nov; 83 Suppl 1():330-3. PubMed ID: 3253502
[No Abstract] [Full Text] [Related]
77. Aromatic constituents of Uvaria grandiflora.
Ankisetty S; ElSohly HN; Li XC; Khan SI; Tekwani BL; Smillie T; Walker L
J Nat Prod; 2006 Apr; 69(4):692-4. PubMed ID: 16643056
[TBL] [Abstract][Full Text] [Related]
78. Activity, toxicity and analysis of resistance of essential oil from Chenopodium ambrosioides after intraperitoneal, oral and intralesional administration in BALB/c mice infected with Leishmania amazonensis: a preliminary study.
Monzote L; Montalvo AM; Scull R; Miranda M; Abreu J
Biomed Pharmacother; 2007; 61(2-3):148-53. PubMed ID: 17254746
[TBL] [Abstract][Full Text] [Related]
79. Down regulation of KMP-11 in Leishmania infantum axenic antimony resistant amastigotes as revealed by a proteomic screen.
El Fadili K; Drummelsmith J; Roy G; Jardim A; Ouellette M
Exp Parasitol; 2009 Sep; 123(1):51-7. PubMed ID: 19500579
[TBL] [Abstract][Full Text] [Related]
80. Advances and perspectives in Leishmania cell based drug-screening procedures.
Sereno D; Cordeiro da Silva A; Mathieu-Daude F; Ouaissi A
Parasitol Int; 2007 Mar; 56(1):3-7. PubMed ID: 17079188
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
